openPR Logo
Press release

Global Cardiovascular Pharmaceuticals Market to be Propelled by Growing Investment in Research and Drug Development, and Increasing Prevalence of Heart Failure by CAGR of 5% During 2023- 2033

11-15-2022 08:40 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Kenneth Research

/ PR Agency: Kenneth Research
Cardiovascular Pharmaceuticals Market

Cardiovascular Pharmaceuticals Market

Kenneth Research published a report titled "Cardiovascular Pharmaceuticals Market: Global Demand Analysis & Opportunity Outlook 2033" which delivers detailed overview of the global cardiovascular pharmaceuticals market in terms of market segmentation by drug class, distribution channel, indication and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
Detailed description: https://www.kennethresearch.com/report-details/cardiovascular-pharmaceuticals-market/10080125
The global cardiovascular pharmaceuticals market is expected to grow at ~5% CAGR over the forecast period, i.e., 2023-2033. The market is segmented by indication into hypertension, arrhythmia, coronary artery disease, and hyperlipidemia. Out of these, the hypertension segment is expected to hold the largest share over the forecast period in the global cardiovascular pharmaceuticals market. This can be attributed to unhealthy lifestyle choices and lack of exercise among the population.
The global cardiovascular pharmaceuticals market is estimated to grow on the back of rising health care costs. Rising demand for more effective cardiovascular drugs followed by growing investment in research and drug development, rising hospitalization and number of admissions in critical care units, increasing prevalence of heart failure, and surge in availability of reimbursement policies is further anticipated to increase the growth of the global cardiovascular pharmaceuticals market.
Geographically, the global cardiovascular pharmaceuticals market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of them, the market in the North America region is projected to hold the largest market share by the end of 2033. This can be attributed to the rise in stress, anxiety, and obesity which is leading to diabetes and heart disease as well as atrial fibrillation, coronary artery disease, and strokes.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Increasing Prevalence of Heart Failure to Boost the Market Growth
Heart failure is a common complication of cardiovascular disorders. Resulting from poor lifestyle decisions, such as eating a lot of salt, smoking, abusing alcohol or drugs, or not taking preventative medications as prescribed
Furthermore, heart failure is becoming more common, with an estimated 27 million people suffering from the disease worldwide.
However, adverse effects of heart medication, expiration of several medications patents, and high cost of cardiovascular drugs are expected to operate as key restraint to the growth of global cardiovascular pharmaceuticals market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global cardiovascular pharmaceuticals market which includes company profiling of Bristol-Myers Squibb Company, Bayer AG, Pfizer Inc., Janssen Pharmaceuticals, Inc., Novartis AG, Merck & Co., AstraZeneca plc, Sanofi S.A., Gilead Sciences, Inc., F. Hoffmann-La Roche, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global cardiovascular pharmaceuticals market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.kennethresearch.com/sample-request-10080125
Kenneth Research is a leading service provider for strategic market research company and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: sales@kennethresearch.com
U.S. Phone: +1 313 462 0609

1412 Broadway, 21st Floor Suite MA111, New York

Kenneth Research provides market research reports to different individuals, industry, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 100,000 research reports provided by more than 25 market research publishers across different industries. Our collection of market research solutions covers both macro level and as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services globally across different industries. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products' demand, growth and opportunities for new and existing players.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cardiovascular Pharmaceuticals Market to be Propelled by Growing Investment in Research and Drug Development, and Increasing Prevalence of Heart Failure by CAGR of 5% During 2023- 2033 here

News-ID: 2806636 • Views: 299

More Releases from Kenneth Research

Global Family Office Market to be Propelled by Surging Number of New Businesses …
Kenneth Research published a report titled "Family Office Market: Global Demand Analysis & Opportunity Outlook 2031" which delivers detailed overview of the global family office market in terms of market segmentation by services, type, net worth managed, and by region. Access Full Description: https://www.kennethresearch.com/report-details/family-office-market/10346745 Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that
Photomask Market Growth Analysis by Revenue, Size, Share, Scenario on Latest Tre …
Kenneth Research provides an extensive study by our analysts which offers forecast assessment by correlating the historical data with key market dynamics. The Photomask Market further includes trends and opportunities that are highlighted, along with the market valuation. The market is segmented by segments and portrays the industry overview along with elaborate description of the market for the forecast period 2020-2025. The report also constitutes future growth statistics which is
Embedded Systems Market 2020 New Innovations Trends, Research, Global Share and …
Kenneth Research provides an extensive study by our analysts which offers forecast assessment by correlating the historical data with key market dynamics. The Embedded Systems Market further includes trends and opportunities that are highlighted, along with the market valuation. The market is segmented by segments and portrays the industry overview along with elaborate description of the market for the forecast period 2020-2025. The report also constitutes future growth statistics which
DNS Service Market : Industry Development Scenario and Forecast to 2025
Global DNS Service Market to reach USD 600 million by 2025.Global DNS Service Market valued approximately USD 230 million in 2016 is anticipated to grow with a healthy growth rate of more than 12% over the forecast period 2018-2025. The DNS Service Market is continuously growing across the world over the coming years. The major driving factor of global DNS Service market are increasing awareness to safeguard the websites from

All 5 Releases


More Releases for Pharmaceuticals

Opioid Use Disorder Market ||Indivior, Alkermes, Titan Pharmaceuticals, Hikma Ph …
Zion Market Research published a new 110+ pages industry research “Opioid Use Disorder Market by Drug (Buprenorphine, Methadone and Naltrexone) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025” is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data
Global Halal Pharmaceuticals Market 2019 - CCM Pharmaceuticals, Pharmaniaga, Ros …
This new report by Eon Market Research, titled “Global Halal Pharmaceuticals Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Halal Pharmaceuticals industry at a global as well as regional and country level. Key facts analyzed in this report include the Halal Pharmaceuticals market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study
Topical Antibiotic Pharmaceuticals Market 2016-2026 | Teva Pharmaceuticals, Perr …
Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections. Skin and soft tissue infections (SSTIs) involve microbial invasion of the skin and underlying soft tissues infections are one of the most commonly occurring conditions amongst people. Most of these infections are minor and chronic in
Lipid Disorder Treatment Market to 2017 - 2026: Teva Pharmaceuticals, Mylan Phar …
Researchmoz added Most up-to-date research on "Lipid Disorder Treatment Market - Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2026" to its huge collection of research reports Extensive research report on global lipid disorders treatment market skilfully crafted by Transparency Market Research depicts the current as well as future scenario of various drugs used to treat lipid disorders. The research study includes analysis on key developments that are
Halal Pharmaceuticals 2018 Global Market Key Players -CCM Pharmaceuticals, Pharm …
Halal Pharmaceuticals Market 2018 Wiseguyreports.Com Adds “Halal Pharmaceuticals – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Description:  In this report, the global Halal Pharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions,
Global Wilson's Disease Market 2017- Valeant Pharmaceuticals International, Meda …
The Global Wilson's Disease Market 2017 Research Report includes a complete and meticulous study of Wilson's Disease industry covering different aspects like market volume, market Share, market strategies, Wilson's Disease growth trends, variety of applications, utilization volume, demand and supply analysis, production capacity and Wilson's Disease industry cost structures during Forecast period from 2017 to 2022. The report titled Global Wilson's Disease Market 2017 provides the comprehensive study of Wilson's Disease